{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:46:11Z","timestamp":1778510771559,"version":"3.51.4"},"reference-count":80,"publisher":"Informa UK Limited","issue":"15","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Microbiol."],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.2217\/fmb-2019-0135","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T09:05:07Z","timestamp":1569920707000},"page":"1293-1308","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":19,"title":["Eravacycline: A New Treatment Option for Complicated Intra-Abdominal Infections in the Age of Multidrug Resistance"],"prefix":"10.1080","volume":"14","author":[{"given":"Joseph S","family":"Solomkin","sequence":"first","affiliation":[{"name":"Department of Surgery, University of Cincinnati College of Medicine, 6005 Given Road Cincinnati, OH45243, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angie","family":"Sway","sequence":"additional","affiliation":[{"name":"Medical Writing, World Surgical Infection Society, Cincinnati, OH45243, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Lawrence","sequence":"additional","affiliation":[{"name":"Medical Affairs, Tetraphase Pharmaceuticals, Watertown, MA02472, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Olesky","sequence":"additional","affiliation":[{"name":"Medical Affairs, Tetraphase Pharmaceuticals, Watertown, MA02472, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey","family":"Izmailyan","sequence":"additional","affiliation":[{"name":"Medical Affairs, Tetraphase Pharmaceuticals, Watertown, MA02472, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry","family":"Tsai","sequence":"additional","affiliation":[{"name":"Medical Affairs, Tetraphase Pharmaceuticals, Watertown, MA02472, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2019,10]]},"reference":[{"key":"e_1_3_4_3_1","unstructured":"European Centre for Disease Prevention and Control . Antimicrobial resistance. https:\/\/www.ecdc.europa.eu\/en\/antimicrobial-resistance"},{"key":"e_1_3_4_4_1","unstructured":"Infectious Diseases Society of America . Antimicrobial resistance: a public health crisis (2016)."},{"key":"e_1_3_4_5_1","unstructured":"Centers for Disease Control and Prevention . Antibiotic resistance threats in the United States (2013). https:\/\/www.cdc.gov\/drugresistance\/pdf\/ar-threats-2013-508.pdf"},{"key":"e_1_3_4_6_1","unstructured":"World Health Organization . Antimicrobial resistance (2018). https:\/\/www.who.int\/antimicrobial-resistance\/en\/"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2018.04.005"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm318"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2015.993381"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000111"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389450116666151001112859"},{"key":"e_1_3_4_12_1","volume-title":"European Congress of Clinical Microbiology and Infectious Diseases","author":"Harris P TP","year":"2018","unstructured":"Harris P TP , DavidLye D, MoY. The MERINO trial: piperacillin-tazobactam versus meropenem for the definitive treatment of bloodstream infections caused by third-generation cephalosporin nonsusceptible Escherichia coli or Klebsiella spp.: an international multi-centre open label non-inferiority randomised controlled trial. Presented at: European Congress of Clinical Microbiology and Infectious Diseases. Madrid, Spain, 21\u201324 April 2018."},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw282"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit020"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00079-17"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-1054-3"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2019.01.020"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S150447"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00080"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku356"},{"key":"e_1_3_4_21_1","unstructured":"Surveillance of antimicrobial resistance in Europe \u2013 annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2017. In: Antimicrobial Resistance Surveillance in Europe. European Centre for Disease Prevention and Control Stockholm Sweden (2018)."},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2015.05.005"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2017.156"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw398"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2008.12.001"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2006.100"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365540701449377"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119956"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2016.261"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1086\/649554"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13017-017-0141-6"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30398-X"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2017.0904"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1086\/526444"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1978.01370190075013"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1600673"},{"issue":"2","key":"e_1_3_4_37_1","first-page":"122","article-title":"Clinical and scientific importance of source control in abdominal infections: summary of a symposium","volume":"42","author":"Bohnen JM","year":"1999","unstructured":"Bohnen JM , MarshallJC, FryDE, JohnsonSB, SolomkinJS. Clinical and scientific importance of source control in abdominal infections: summary of a symposium. Can. J. Surg.42(2), 122\u2013126 (1999).","journal-title":"Can. J. Surg."},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-004-7505-2"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/148.2.322"},{"issue":"4","key":"e_1_3_4_40_1","first-page":"303","article-title":"The role of Pseudomonas species in patients treated with ampicillin and Sulbactam for gangrenous and perforated appendicitis","volume":"161","author":"Yellin AE","year":"1985","unstructured":"Yellin AE , HeseltinePN, BerneTVet al. The role of Pseudomonas species in patients treated with ampicillin and Sulbactam for gangrenous and perforated appendicitis. Surg. Ggynecol. Obstet.161(4), 303\u2013307 (1985).","journal-title":"Surg. Ggynecol. Obstet."},{"issue":"3","key":"e_1_3_4_41_1","first-page":"Cd001439","article-title":"Antibiotics versus placebo for prevention of postoperative infection after appendicectomy","author":"Andersen BR","year":"2005","unstructured":"Andersen BR , KallehaveFL, AndersenHK. Antibiotics versus placebo for prevention of postoperative infection after appendicectomy. Cochrane Database Syst. Rev. (3), Cd001439 (2005).","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02206-17"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2017.12.013"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00436-16"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2017.01.004"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2018.06.016"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2017.06.022"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.06187-11"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04809-14"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2016.73"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-018-1349-7"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ097"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw133"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01614-13"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2016.4237"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01174-18"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1086\/431674"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1086\/431676"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2013.12.007"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-297"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.10.009"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2010.03122.x"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.12163"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks301"},{"issue":"9","key":"e_1_3_4_65_1","first-page":"1319","article-title":"Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum \u03b2-lactamase bacteremia","volume":"60","author":"Tamma PD","year":"2015","unstructured":"Tamma PD , HanJH, RockCet al. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum \u03b2-lactamase bacteremia. Clin. Infect. Dis.60(9), 1319\u20131325 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00607-13"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature.2017.21550"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2017.03.012"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.7b00243"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy576"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.09.001"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00989-17"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix246"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix211"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-018-0214-1"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03478.x"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy768"},{"key":"e_1_3_4_78_1","unstructured":"US FDA . Guidance for industry: complicated intra-abdominal infections: developing drugs for treatment (2018). https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/complicated-intra-abdominal-infections-developing-drugs-treatment"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.SLA.0000048551.32606.73"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000230024.84190.a8"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2016.1188234"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx181"}],"container-title":["Future Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fmb-2019-0135","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:41:07Z","timestamp":1719124867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fmb-2019-0135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":80,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.2217\/fmb-2019-0135"],"URL":"https:\/\/doi.org\/10.2217\/fmb-2019-0135","relation":{},"ISSN":["1746-0913","1746-0921"],"issn-type":[{"value":"1746-0913","type":"print"},{"value":"1746-0921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-05-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}